Package 0093-5526-06

{"route": ["ORAL"], "spl_id": "61209ea1-63c7-43fc-ac32-d840a8a0906a", "openfda": {"unii": ["4MT4VIE29P"], "rxcui": ["402246", "402247", "664741"], "spl_set_id": ["654b7e08-33d8-47e7-b37f-3681e79c7b8b"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "60 CAPSULE in 1 BOTTLE (0093-5526-06)", "package_ndc": "0093-5526-06", "marketing_start_date": "20171227"}], "brand_name": "Atazanavir Sulfate", "product_id": "0093-5526_61209ea1-63c7-43fc-ac32-d840a8a0906a", "dosage_form": "CAPSULE", "pharm_class": ["Cytochrome P450 2C8 Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "HIV Protease Inhibitors [MoA]", "Protease Inhibitor [EPC]", "UDP Glucuronosyltransferases Inhibitors [MoA]", "UGT1A1 Inhibitors [MoA]"], "product_ndc": "0093-5526", "generic_name": "Atazanavir Sulfate", "labeler_name": "Teva Pharmaceuticals USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Atazanavir Sulfate", "active_ingredients": [{"name": "ATAZANAVIR SULFATE", "strength": "150 mg/1"}], "application_number": "ANDA091673", "marketing_category": "ANDA", "marketing_start_date": "20171227", "listing_expiration_date": "20261231"}